Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Body mass index, but not vitamin D status, is associated with brain volume change in MS.

Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D.

Neurology. 2018 Nov 14. pii: 10.1212/WNL.0000000000006644. doi: 10.1212/WNL.0000000000006644. [Epub ahead of print]

PMID:
30429274
2.

Multiple sclerosis relapse: Qualitative findings from clinician and patient interviews.

Matza LS, Kim K, Phillips G, Zorn K, Chan KS, Smith KC, Mowry EM.

Mult Scler Relat Disord. 2018 Sep 26;27:139-146. doi: 10.1016/j.msard.2018.09.029. [Epub ahead of print]

PMID:
30384199
3.

We need to conduct clinical trials of disease-modifying therapy in pregnancy to optimize care of women with MS - Yes.

Alvarez E, Mowry EM.

Mult Scler. 2018 Oct 22:1352458518794061. doi: 10.1177/1352458518794061. [Epub ahead of print] No abstract available.

PMID:
30346221
4.

Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Caldito NG, Saidha S, Sotirchos ES, Dewey BE, Cowley NJ, Glaister J, Fitzgerald KC, Al-Louzi O, Nguyen J, Rothman A, Ogbuokiri E, Fioravante N, Feldman S, Kwakyi O, Risher H, Kimbrough D, Frohman TC, Frohman E, Balcer L, Crainiceanu C, Van Zijl PCM, Mowry EM, Reich DS, Oh J, Pham DL, Prince J, Calabresi PA.

Brain. 2018 Nov 1;141(11):3115-3129. doi: 10.1093/brain/awy245.

PMID:
30312381
5.

Incorporating machine learning approaches to assess putative environmental risk factors for multiple sclerosis.

Mowry EM, Hedström AK, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, Bellesis KH, Briggs FBS, Olsson T, Alfredsson L, Barcellos LF.

Mult Scler Relat Disord. 2018 Aug;24:135-141. doi: 10.1016/j.msard.2018.06.009. Epub 2018 Jun 23.

PMID:
30005356
6.

Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis.

Fitzgerald KC, Vizthum D, Henry-Barron B, Schweitzer A, Cassard SD, Kossoff E, Hartman AL, Kapogiannis D, Sullivan P, Baer DJ, Mattson MP, Appel LJ, Mowry EM.

Mult Scler Relat Disord. 2018 Jul;23:33-39. doi: 10.1016/j.msard.2018.05.002. Epub 2018 May 5.

PMID:
29753994
7.

The Evidence for Dietary Interventions and Nutritional Supplements as Treatment Options in Multiple Sclerosis: a Review.

Mische LJ, Mowry EM.

Curr Treat Options Neurol. 2018 Mar 17;20(4):8. doi: 10.1007/s11940-018-0494-5. Review.

PMID:
29549521
8.

A review of vitamin D supplementation as disease-modifying therapy.

Shoemaker TJ, Mowry EM.

Mult Scler. 2018 Jan;24(1):6-11. doi: 10.1177/1352458517738131.

PMID:
29307295
9.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
10.

The Dynamics of the Gut Microbiome in Multiple Sclerosis in Relation to Disease.

Mowry EM, Glenn JD.

Neurol Clin. 2018 Feb;36(1):185-196. doi: 10.1016/j.ncl.2017.08.008. Review.

PMID:
29157399
11.

Metabolic alterations in multiple sclerosis and the impact of vitamin D supplementation.

Bhargava P, Fitzgerald KC, Calabresi PA, Mowry EM.

JCI Insight. 2017 Oct 5;2(19). pii: 95302. doi: 10.1172/jci.insight.95302. [Epub ahead of print]

12.

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability.

LaRocca NG, Hudson LD, Rudick R, Amtmann D, Balcer L, Benedict R, Bermel R, Chang I, Chiaravalloti ND, Chin P, Cohen JA, Cutter GR, Davis MD, DeLuca J, Feys P, Francis G, Goldman MD, Hartley E, Kapoor R, Lublin F, Lundstrom G, Matthews PM, Mayo N, Meibach R, Miller DM, Motl RW, Mowry EM, Naismith R, Neville J, Panagoulias J, Panzara M, Phillips G, Robbins A, Sidovar MF, Smith KE, Sperling B, Uitdehaag BM, Weaver J; Multiple Sclerosis Outcome Assessments Consortium (MSOAC).

Mult Scler. 2018 Oct;24(11):1469-1484. doi: 10.1177/1352458517723718. Epub 2017 Aug 11.

13.

Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis.

Foley RW, Tagg NT, Schindler MK, Fenton KM, Reich DS, Cortese I, Mowry EM.

Mult Scler. 2017 Sep;23(10):1424-1427. doi: 10.1177/1352458517702533. Epub 2017 Jun 22.

14.

Follow-Up of Emergency Department MRI Scans Suggesting New Diagnosis of CNS Demyelination.

Pakpoor J, Saylor D, Izbudak I, Liu L, Mowry EM, Probasco J, Yousem DM.

AJR Am J Roentgenol. 2017 Jul;209(1):171-175. doi: 10.2214/AJR.16.17279. Epub 2017 May 2.

PMID:
28463541
15.

PML in natalizumab-treated multiple sclerosis: Modeling errors and risk miscalculations.

Mowry EM, McArthur JC.

Neurology. 2017 Mar 21;88(12):1110-1111. doi: 10.1212/WNL.0000000000003749. Epub 2017 Feb 22. No abstract available.

PMID:
28228562
16.

Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities.

Motl RW, Mowry EM, Ehde DM, LaRocca NG, Smith KE, Costello K, Shinto L, Ng AV, Sullivan AB, Giesser B, McCully KK, Fernhall B, Bishop M, Plow M, Casaccia P, Chiaravalloti ND.

Mult Scler. 2018 Mar;24(3):262-267. doi: 10.1177/1352458516687404. Epub 2017 Jan 12.

17.

Neuromyelitis optica unmasked by a spinal dural arteriovenous fistula.

Freund B, Mowry EM, McR, Levy M, Newsome SD.

J Neuroimmunol. 2016 Nov 15;300:18-20. doi: 10.1016/j.jneuroim.2016.10.005. Epub 2016 Oct 12.

PMID:
27806871
18.

Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?

Pakpoor J, Saylor D, Izbudak I, Liu L, Mowry EM, Yousem DM.

AJNR Am J Neuroradiol. 2017 Jan;38(1):12-17. doi: 10.3174/ajnr.A4953. Epub 2016 Oct 6.

19.

Environmental and genetic factors in pediatric inflammatory demyelinating diseases.

Waubant E, Ponsonby AL, Pugliatti M, Hanwell H, Mowry EM, Hintzen RQ.

Neurology. 2016 Aug 30;87(9 Suppl 2):S20-7. doi: 10.1212/WNL.0000000000003029. Review.

PMID:
27572857
20.

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary.

Mowry EM.

Mult Scler. 2016 Sep;22(10):1263-5. doi: 10.1177/1352458516660206. Epub 2016 Jul 21. No abstract available.

PMID:
27444561
21.

Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer.

Williams TJ, Benavides DR, Patrice KA, Dalmau JO, de Ávila AL, Le DT, Lipson EJ, Probasco JC, Mowry EM.

JAMA Neurol. 2016 Aug 1;73(8):928-33. doi: 10.1001/jamaneurol.2016.1399.

PMID:
27271951
22.

Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.

Glenn JD, Mowry EM.

J Interferon Cytokine Res. 2016 Jun;36(6):347-57. doi: 10.1089/jir.2015.0177. Epub 2016 May 4. Review.

23.

High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies.

Hedström AK, Mowry EM, Gianfrancesco MA, Shao X, Schaefer CA, Shen L, Olsson T, Barcellos LF, Alfredsson L.

J Neurol Neurosurg Psychiatry. 2016 May;87(5):454-60. doi: 10.1136/jnnp-2015-312176. Epub 2016 Mar 3.

24.

Genetic predictors of relapse rate in pediatric MS.

Graves JS, Barcellos LF, Shao X, Noble J, Mowry EM, Quach H, Belman A, Casper TC, Krupp LB, Waubant E; U.S. Network of Pediatric MS Centers.

Mult Scler. 2016 Oct;22(12):1528-1535. Epub 2016 Jan 14.

25.

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.

Sotirchos ES, Bhargava P, Eckstein C, Van Haren K, Baynes M, Ntranos A, Gocke A, Steinman L, Mowry EM, Calabresi PA.

Neurology. 2016 Jan 26;86(4):382-90. doi: 10.1212/WNL.0000000000002316. Epub 2015 Dec 30.

26.

Evidence for the Importance of Vitamin D Status in Neurologic Conditions.

Yeshokumar AK, Saylor D, Kornberg MD, Mowry EM.

Curr Treat Options Neurol. 2015 Dec;17(12):51. doi: 10.1007/s11940-015-0380-3.

PMID:
26538263
27.

Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.

Mowry EM, Pelletier D, Gao Z, Howell MD, Zamvil SS, Waubant E.

Eur J Neurol. 2016 Feb;23(2):327-32. doi: 10.1111/ene.12844. Epub 2015 Oct 31.

PMID:
26518224
28.

Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.

Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, Cassard SD, Hollis BW, Crainiceanu C, Mowry EM.

Mult Scler. 2016 May;22(6):753-60. doi: 10.1177/1352458515600248. Epub 2015 Aug 18.

29.

Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis.

Maghzi AH, Revirajan N, Julian LJ, Spain R, Mowry EM, Liu S, Jin C, Green AJ, McCulloch CE, Pelletier D, Waubant E.

Mult Scler Relat Disord. 2014 Nov;3(6):720-7. doi: 10.1016/j.msard.2014.07.003. Epub 2014 Jul 23.

PMID:
25891551
30.

Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.

Graves J, Vinayagasundaram U, Mowry EM, Matthews IR, Marino JA, Cheng J, Waubant E.

Mult Scler Relat Disord. 2014 Mar;3(2):244-52. doi: 10.1016/j.msard.2013.10.003. Epub 2013 Oct 25.

PMID:
25878012
31.

Gut microbiota in multiple sclerosis: possible influence of immunomodulators.

Cantarel BL, Waubant E, Chehoud C, Kuczynski J, DeSantis TZ, Warrington J, Venkatesan A, Fraser CM, Mowry EM.

J Investig Med. 2015 Jun;63(5):729-34. doi: 10.1097/JIM.0000000000000192.

32.

A randomized controlled phase II trial of riluzole in early multiple sclerosis.

Waubant E, Maghzi AH, Revirajan N, Spain R, Julian L, Mowry EM, Marcus J, Liu S, Jin C, Green A, McCulloch CE, Pelletier D.

Ann Clin Transl Neurol. 2014 May;1(5):340-7. doi: 10.1002/acn3.60. Epub 2014 Apr 14.

33.

Protective environmental factors for neuromyelitis optica.

Graves J, Grandhe S, Weinfurtner K, Krupp L, Belman A, Chitnis T, Ness J, Weinstock-Guttman B, Gorman M, Patterson M, Rodriguez M, Lotze T, Aaen G, Mowry EM, Rose JW, Simmons T, Casper TC, James J, Waubant E; US Network of Pediatric Multiple Sclerosis Centers.

Neurology. 2014 Nov 18;83(21):1923-9. doi: 10.1212/WNL.0000000000001001. Epub 2014 Oct 22.

34.

The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.

Bhargava P, Cassard S, Steele SU, Azevedo C, Pelletier D, Sugar EA, Waubant E, Mowry EM.

Contemp Clin Trials. 2014 Nov;39(2):288-93. doi: 10.1016/j.cct.2014.10.004. Epub 2014 Oct 12.

PMID:
25311447
35.

Gut microbiome and multiple sclerosis.

Bhargava P, Mowry EM.

Curr Neurol Neurosci Rep. 2014 Oct;14(10):492. doi: 10.1007/s11910-014-0492-2. Review.

PMID:
25204849
36.

Outcome measures in multiple sclerosis.

Bermel R, Waldman A, Mowry EM.

Mult Scler Int. 2014;2014:439375. doi: 10.1155/2014/439375. Epub 2014 May 5. No abstract available.

37.

Association of multiple sclerosis susceptibility variants and early attack location in the CNS.

Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E.

PLoS One. 2013 Oct 10;8(10):e75565. doi: 10.1371/journal.pone.0075565. eCollection 2013.

38.

Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.

Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E.

PLoS One. 2013 Oct 9;8(10):e75416. doi: 10.1371/journal.pone.0075416. eCollection 2013.

39.

Brainstem encephalitis: etiologies, treatment, and predictors of outcome.

Tan IL, Mowry EM, Steele SU, Pardo CA, McArthur JC, Nath A, Venkatesan A.

J Neurol. 2013 Sep;260(9):2312-9. doi: 10.1007/s00415-013-6986-z. Epub 2013 Jun 9.

40.

Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.

Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, James JA.

Mult Scler. 2013 Jun;19(7):891-5. doi: 10.1177/1352458512469693. Epub 2012 Dec 11.

41.

The influence of nutritional factors on the prognosis of multiple sclerosis.

von Geldern G, Mowry EM.

Nat Rev Neurol. 2012 Dec;8(12):678-89. doi: 10.1038/nrneurol.2012.194. Epub 2012 Oct 2. Review.

PMID:
23026980
42.

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.

Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D.

Ann Neurol. 2012 Aug;72(2):234-40. doi: 10.1002/ana.23591.

43.

Relapse severity and recovery in early pediatric multiple sclerosis.

Fay AJ, Mowry EM, Strober J, Waubant E.

Mult Scler. 2012 Jul;18(7):1008-12. doi: 10.1177/1352458511431725. Epub 2011 Dec 19.

PMID:
22183939
44.

Vitamin D: evidence for its role as a prognostic factor in multiple sclerosis.

Mowry EM.

J Neurol Sci. 2011 Dec 15;311(1-2):19-22. doi: 10.1016/j.jns.2011.06.035. Epub 2011 Jul 16. Review.

PMID:
21762931
45.

Common viruses associated with lower pediatric multiple sclerosis risk.

Waubant E, Mowry EM, Krupp L, Chitnis T, Yeh EA, Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg JR, James JA; US Pediatric MS Network.

Neurology. 2011 Jun 7;76(23):1989-95. doi: 10.1212/WNL.0b013e31821e552a.

46.

Vitamin D in African Americans with multiple sclerosis.

Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ.

Neurology. 2011 May 24;76(21):1824-30. doi: 10.1212/WNL.0b013e31821cccf5.

47.

Natural history of multiple sclerosis: early prognostic factors.

Mowry EM.

Neurol Clin. 2011 May;29(2):279-92. doi: 10.1016/j.ncl.2011.01.001. Review.

PMID:
21439441
48.

Switching multiple sclerosis patients with breakthrough disease to second-line therapy.

Castillo-Trivino T, Mowry EM, Gajofatto A, Chabas D, Crabtree-Hartman E, Cree BA, Goodin DS, Green AJ, Okuda DT, Pelletier D, Zamvil SS, Vittinghoff E, Waubant E.

PLoS One. 2011 Feb 3;6(2):e16664. doi: 10.1371/journal.pone.0016664.

49.

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome.

Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, Waubant E, Pelletier D.

Neurology. 2011 Feb 22;76(8):686-92. doi: 10.1212/WNL.0b013e31820d8b1d. Epub 2011 Jan 26.

50.

Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.

Mowry EM, James JA, Krupp LB, Waubant E.

Mult Scler. 2011 Jun;17(6):666-71. doi: 10.1177/1352458510394398. Epub 2011 Jan 6. Erratum in: Mult Scler. 2011 Dec;17(12):1539.

Supplemental Content

Loading ...
Support Center